Predicting alloreactivity in transplantation

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Geneugelijk, Kirsten ^a   Thus, Kirsten Anne ^a   Spierings, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AMINO ACID; HLA ANTIGEN; HLA DPB1 ANTIGEN; IMMUNOGLOBULIN G; EPITOPE;

ALLOIMMUNITY; ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CLINICAL PATHWAY; CYTOTOXIC T LYMPHOCYTE; DONOR SELECTION; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MASS SCREENING; MOLECULAR RECOGNITION; ORGAN TRANSPLANTATION; REVIEW; T LYMPHOCYTE; ALLOTRANSPLANTATION; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LEUKOCYTE; PROCEDURES;

EPITOPES; GRAFT REJECTION; GRAFT VS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HOST VS GRAFT REACTION; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; LEUKOCYTES; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84901008802     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/159479     Document Type: Review

References (124)

1. Dunn T. B., Noreen H., Gillingham K., Maurer D., Ozturk O. G., Pruett T. L., Bray R. A., Gebel H. M., Matas A. J., Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. The American Journal of Transplantation 2011 11 10 2132 2143 2-s2.0-80053307061 10.1111/j.1600-6143. 2011.03640.x
2. Rizzari M. D., Suszynski T. M., Gillingham K. J., Matas A. J., Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors. Transplantation 2011 92 1 70 55 10.1097/TP.0b013e31821cded7
3. Vu L. T., Baxter-Lowe L. A., Garcia J., McEnhill M., Summers P., Hirose R., Lee M., Stock P. G., HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Archives of Surgery 2011 146 7 824 829 2-s2.0-79960407045 10.1001/archsurg.2011.147
4. Crocchiolo R., Zino E., Vago L., Oneto R., Bruno B., Pollichieni S., Sacchi N., Sormani M. P., Marcon J., Lamparelli T., Fanin R., Garbarino L., Miotti V., Bandini G., Bosi A., Ciceri F., Bacigalupo A., Fleischhauer K., Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009 114 7 1437 1444 2-s2.0-70349342800 10.1182/blood-2009-01-200378
5. Flomenberg N., Baxter-Lowe L. A., Confer D., Fernandez-Vina M., Filipovich A., Horowitz M., Hurley C., Kollman C., Anasetti C., Noreen H., Begovich A., Hildebrand W., Petersdorf E., Schmeckpeper B., Setterholm M., Trachtenberg E., Williams T., Yunis E., Weisdorf D., Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004 104 7 1923 1930 2-s2.0-4644359708 10.1182/blood-2004-03-0803 (Pubitemid 39297840)
6. Kawase T., Morishima Y., Matsuo K., Kashiwase K., Inoko H., Saji H., Kato S., Juji T., Kodera Y., Sasazuki T., High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007 110 7 2235 2241 2-s2.0-34948865802 10.1182/blood-2007-02-072405 (Pubitemid 47523140)
7. Kawase T., Matsuo K., Kashiwase K., HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009 113 12 2851 2858 10.1182/blood-2008-08-171934
8. Morishima Y., Sasazuki T., Inoko H., The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002 99 11
9. Mosaad Y. M., Kamel H., HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors. The Egyptian Journal of Immunology 2005 12 2 21 28 2-s2.0-38449116432
10. Doxiadis I. I. N., Smits J. M. A., Schreuder G. M. T., Persijn G. G., Van Houwelingen H. C., Van Rood J. J., Claas F. H. J., Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. The Lancet 1996 348 9031 850 853 2-s2.0-0030604914 10.1016/S0140-6736(96)02296-9 (Pubitemid 26320900)
11. Mifsud N. A., Purcell A. W., Chen W., Holdsworth R., Tait B. D., McCluskey J., Immunodominance hierarchies and gender bias in direct TCD8-cell alloreactivity. The American Journal of Transplantation 2008 8 1 121 132 2-s2.0-37549049801 10.1111/j.1600-6143.2007.02044.x
12. Fleischhauer K., Kernan N. A., O'Reilly R. J., Dupont B., Yang S. Y., Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. The New England Journal of Medicine 1990 323 26 1818 1822 2-s2.0-0025634104
13. Macdonald W. A., Purcell A. W., Mifsud N. A., Ely L. K., Williams D. S., Chang L., Gorman J. J., Clements C. S., Kjer-Nielsen L., Koelle D. M., Burrows S. R., Tait B. D., Holdsworth R., Brooks A. G., Lovrecz G. O., Lu L., Rossjohn J., McCluskey J., A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. The Journal of Experimental Medicine 2003 198 5 679 691 2-s2.0-0042887021 10.1084/jem.20030066 (Pubitemid 37087768)
14. Heemskerk M. B. A., Cornelissen J. J., Roelen D. L., van Rood J. J., Claas F. H. J., Doxiadis I. I. N., Oudshoorn M., Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplantation 2007 40 3 193 200 2-s2.0-34547199983 10.1038/sj.bmt. 1705721 (Pubitemid 47108461)
15. Lefaucheur C., Suberbielle-Boissel C., Hill G. S., Nochy D., Andrade J., Antoine C., Gautreau C., Charron D., Glotz D., Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. The American Journal of Transplantation 2008 8 2 324 331 2-s2.0-38149041728 10.1111/j.1600-6143.2007. 02072.x
16. Brand A., Doxiadis I. N., Roelen D. L., On the role of HLA antibodies in hematopoietic stem cell transplantation. Tissue Antigens 2013 81 1 1 11 10.1111/tan.12040
17. Terasaki P. I., Cai J., Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008 86 3 377 383 2-s2.0-50549089591 10.1097/TP.0b013e31817c4cb8
18. Spellman S., Bray R., Rosen-Bronson S., Haagenson M., Klein J., Flesch S., Vierra-Green C., Anasetti C., The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010 115 13 2704 2708 2-s2.0-77950965205 10.1182/blood-2009-09-244525
19. Steele D. J. R., Laufer T. M., Smiley S. T., Ando Y., Grusby M. J., Glimcher L. H., Auchincloss H. Jr., Two levels of help for B cell alloantibody production. The Journal of Experimental Medicine 1996 183 2 699 703 2-s2.0-0030029057 10.1084/jem.183.2.699 (Pubitemid 26059527)
20. Duquesnoy R. J., HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients. Transplantation Proceedings 2001 33 1-2 493 497 2-s2.0-0035083933 10.1016/S0041-1345(00)02108-4 (Pubitemid 32237480)
21. Duquesnoy R. J., HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Human Immunology 2002 63 5 339 352 2-s2.0-0036092367 10.1016/S0198-8859(02)00382-8 (Pubitemid 34521366)
22. Duquesnoy R. J., A structurally based approach to determine HLA compatibility at the humoral immune level. Human Immunology 2006 67 11 847 862 2-s2.0-33845914198 10.1016/j.humimm.2006.08.001 (Pubitemid 44828199)
23. Warrens A. N., Lombardi G., Lechler R. I., Presentation and recognition of major and minor histocompatibility antigens. Transplant Immunology 1994 2 2 103 107 2-s2.0-0028308632 10.1016/0966-3274(94)90036-1 (Pubitemid 24228003)
24. Burrows S. R., Khanna R., Burrows J. M., Moss D. J., An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. The Journal of Experimental Medicine 1994 179 4 1155 1161 2-s2.0-0028349005 (Pubitemid 24091774)
25. Burrows S. R., Silins S. L., Moss D. J., Khanna R., Misko I. S., Argaet V. P., T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. The Journal of Experimental Medicine 1995 182 6 1703 1715 2-s2.0-0028783395 10.1084/jem.182.6.1703
26. Burrows S. R., Silins S. L., Khanna R., Burrows J. M., Rischmueller M., McCluskey J., Moss D. J., Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. European Journal of Immunology 1997 27 7 1726 1736 2-s2.0-0030861370 10.1002/eji.1830270720 (Pubitemid 27302856)
27. Morice A., Charreau B., Neveu B., Brouard S., Soulillou J.-P., Bonneville M., Houssaint E., Degauque N., Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules. PLoS ONE 2010 5 8 2-s2.0-77957861661 10.1371/journal.pone.0012120 e12120
28. Landais E., Morice A., Long H. M., Haigh T. A., Charreau B., Bonneville M., Taylor G. S., Houssaint E., EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses. Journal of Immunology 2006 177 3 1427 1433 2-s2.0-33746214869 (Pubitemid 44092475)
29. Elkington R., Khanna R., Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. Blood 2005 105 3 1362 1364 2-s2.0-12844278562 10.1182/blood-2004-07-2602 (Pubitemid 40170915)
30. Amir A. L., Van Der Steen D. M., Hagedoorn R. S., Kester M. G. D., Van Bergen C. A. M., Drijfhout J. W., De Ru A. H., Falkenburg J. H. F., Van Veelen P. A., Heemskerk M. H. M., Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific. Blood 2011 118 26 6733 6742 2-s2.0-84255197321 10.1182/blood-2011-05-354787
31. D'Orsogna L. J. A., Van Besouw N. M., Van Der Meer-Prins E. M. W., Van Der Pol P., Franke-Van Dijk M., Zoet Y. M., Van Der Slik A., Weimar W., Van Kooten C., Mulder A., Roelen D. L., Doxiadis I. I. N., Claas F. H. J., Vaccine-induced allo-hla-reactive memory T cells in a kidney transplantation candidate. Transplantation 2011 91 6 645 651 2-s2.0-79952764290 10.1097/TP.0b013e318208c071
32. Ali J. M., Bolton E. M., Bradley J. A., Pettigrew G. J., Allorecognition pathways in transplant rejection and tolerance. Transplantation 2013 96 8 681 688 10.1097/TP.0b013e31829853ce
33. Game D. S., Lechler R. I., Pathways of allorecognition: implications for transplantation tolerance. Transplant Immunology 2002 10 2-3 101 108 2-s2.0-0036348187 10.1016/S0966-3274(02)00055-2
34. Bolton E. M., Bradley J. A., Pettigrew G. J., Indirect allorecognition: not simple but effective. Transplantation 2008 85 5 667 669 2-s2.0-40849083586 10.1097/TP.0b013e3181664db3 (Pubitemid 351398239)
35. Song E. S., Linsk R., Olson C. A., McMillan M., Goodenow R. S., Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. Proceedings of the National Academy of Sciences of the United States of America 1988 85 6 1927 1931 2-s2.0-0024121498 10.1073/pnas.85.6.1927 (Pubitemid 24315797)
36. Kievits F., Ivanyi P., A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. The Journal of Experimental Medicine 1991 174 1 15 19 2-s2.0-0025856105
37. Fangmann J., Dalchau R., Fabre J. W., Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. The Journal of Experimental Medicine 1992 175 6 1521 1529 2-s2.0-0026566079 10.1084/jem.175.6.1521
38. Herrera O. B., Golshayan D., Tibbott R., Ochoa F. S., James M. J., Marelli-Berg F. M., Lechler R. I., A novel pathway of alloantigen presentation by dendritic cells. Journal of Immunology 2004 173 8 4828 4837 2-s2.0-6344266994 (Pubitemid 39387763)
39. Morelli A. E., Larregina A. T., Shufesky W. J., Sullivan M. L. G., Stolz D. B., Papworth G. D., Zahorchak A. F., Logar A. J., Wang Z., Watkins S. C., Falo L. D. Jr., Thomson A. W., Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004 104 10 3257 3266 2-s2.0-8644286802 10.1182/blood-2004-03-0824 (Pubitemid 39507144)
40. Game D. S., Rogers N. J., Lechler R. I., Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. The American Journal of Transplantation 2005 5 7 1614 1625 2-s2.0-21344442891 10.1111/j.1600-6143.2005.00916.x (Pubitemid 40910443)
41. Sivaganesh S., Harper S. J., Conlon T. M., Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells. Journal of Immunology 2013 190 11 5829 5838
42. Kim Y.-H., Vyth-Dreese F. A., Schrama E., Pave S., Bajema I., Goulmy E., Spierings E., Exogenous addition of minor H antigen HA-1+ dendritic cells to skin tissues ex vivo causes infiltration and activation of HA-1-specific cytotoxic T cells. Biology of Blood and Marrow Transplantation 2011 17 1 69 77 2-s2.0-79956226052 10.1016/j.bbmt.2010.08.006
43. Hönger G., Fornaro I., Granado C., Frequency and determinants of preganancy-induced child-specific sensitization. American Journal of Transplantation 2013 13 3 746 753
44. Hyun J., Park K. D., Yoo Y., Lee B., Han B. Y., Song E. Y., Park M. H., Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients. Transplantation Proceedings 2012 44 1 222 225 2-s2.0-84858729609 10.1016/j.transproceed.2011.12.049
45. Kakaiya R. M., Triulzi D. J., Wright D. J., Steele W. R., Kleinman S. H., Busch M. P., Norris P. J., Hillyer C. D., Gottschall J. L., Rios J. A., Carey P., Glynn S. A., Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010 50 6 1328 1334 2-s2.0-77953099135 10.1111/j.1537-2995.2009.02556.x
46. Morales-Buenrostro L. E., Terasaki P. I., Marino-Vázquez L. A., Lee J.-H., El-Awar N., Alberú J., 'Natural' human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008 86 8 1111 1115 2-s2.0-55949117502 10.1097/TP.0b013e318186d87b
47. Sicard A., Amrouche L., Suberbielle C., Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. American Journal of Transplantation 2014 14 1 193 201
48. Van Kampen C. A., Versteeg-Vd Voort Maarschalk M. F. J., Langerak-Langerak J., Roelen D. L., Claas F. H. J., Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Human Immunology 2002 63 6 452 458 2-s2.0-0035985619 10.1016/S0198-8859(02)00396-8 (Pubitemid 34620080)
49. Gebel H. M., Bray R. A., Nickerson P., Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. The American Journal of Transplantation 2003 3 12 1488 1500 2-s2.0-0346121399 10.1046/j.1600-6135.2003.00273.x (Pubitemid 37541506)
50. Kao K.-J., Scornik J. C., Small S. J., Enzyme-linked immunoassay for anti-HLA antibodies-an alternative to panel studies by lymphocytotoxicity. Transplantation 1993 55 1 192 196 2-s2.0-0027441275 (Pubitemid 23033970)
51. Pei R., Wang G., Tarsitani C., Rojo S., Chen T., Takemura S., Liu A., Lee J., Simultaneous HLA class I and class II antibodies screening with flow cytometry. Human Immunology 1998 59 5 313 322 2-s2.0-0031969007 10.1016/S0198-8859(98)00020-2 (Pubitemid 28225990)
52. Patel R., Terasaki P. I., Significance of the positive crossmatch test in kidney transplantation. The New England Journal of Medicine 1969 280 14 735 739 2-s2.0-0014662180
53. Le Bas-Bernardet S., Hourmant M., Valentin N., Paitier C., Giral-Classe M., Curry S., Follea G., Soulillou J.-P., Bignon J.-D., Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003 75 4 477 482 2-s2.0-0037468391 10.1097/01.TP.0000047311. 77702.59 (Pubitemid 36241142)
54. Rebibou J. M., Chabod J., Bittencourt M. C., Thevénin C., Chalopin J. M., Hervé P., Tiberghien P., Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transplant Immunology 2000 8 2 125 128 2-s2.0-0033626265 10.1016/S0966-3274(00)00019-8
55. Christiaans M. H. L., Overhof R., Haaft A. T., Nieman F., Van Hooff J. P., Van Den Berg-Loonen E. M., No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996 62 9 1341 1347 2-s2.0-0030447032 10.1097/00007890-199611150-00028 (Pubitemid 27008565)
56. Amico P., Hönger G., Steiger J., Schaub S., Utility of the virtual crossmatch in solid organ transplantation. Current Opinion in Organ Transplantation 2009 14 6 656 661 2-s2.0-74349087312 10.1097/MOT. 0b013e328331c169
57. Bielmann D., Hönger G., Lutz D., Mihatsch M. J., Steiger J., Schaub S., Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. The American Journal of Transplantation 2007 7 3 626 632 2-s2.0-33847750774 10.1111/j.1600-6143.2007.01667.x (Pubitemid 46376450)
58. Otten H. G., Verhaar M. C., Borst H. P. E., Hené R. J., Zuilen A. D. V., Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure. The American Journal of Transplantation 2012 12 6 1618 1623 2-s2.0-84857925285 10.1111/j.1600-6143. 2011.03985.x
59. Dankers M. K. A., Witvliet M. D., Roelen D. L., De Lange P., Korfage N., Persijn G. G., Duquesnoy R., Doxiadis I. I. N., Claas F. H. J., The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004 77 8 1236 1239 2-s2.0-2342486013 (Pubitemid 38580303)
60. Kosmoliaptsis V., Bradley J. A., Sharples L. D., Chaudhry A., Key T., Goodman R. S., Taylor C. J., Predicting the immunogenicity of human leukocyte antigen class i alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008 85 12 1817 1825 2-s2.0-49149111790 10.1097/TP.0b013e31817441d6
61. Dankers M. K. A., Heemskerk M. B. A., Duquesnoy R. J., Doxiadis I. I. N., Oudshoorn M., Roelen D. L., Claas F. H. J., HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro. Transplantation 2004 78 1 165 167 2-s2.0-3142702745 10.1097/01.TP. 0000133511.94487.D3 (Pubitemid 39099427)
62. Duquesnoy R., Spellman S., Haagenson M., Wang T., Horowitz M. M., Oudshoorn M., HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biology of Blood and Marrow Transplantation 2008 14 9 1064 1071 2-s2.0-49449086957 10.1016/j.bbmt.2008.07.001
63. Duquesnoy R. J., Takemoto S., De Lange P., Doxiadis I. I. N., Schreuder G. M. T., Persijn G. G., Claas F. H. J., HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 2003 75 6 884 889 2-s2.0-0037468720 10.1097/01.TP.0000055101.20821.AC (Pubitemid 36373464)
64. Laux G., Mytilineos J., Opelz G., Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Transplantation 2004 77 6 902 907 2-s2.0-1842472934 10.1097/01.TP.0000114595. 59168.3B (Pubitemid 38436832)
65. Haririan A., Fagoaga O., Daneshvar H., Morawski K., Sillix D. H., El-Amm J. M., West M. S., Garnick J., Migdal S. D., Gruber S. A., Nehlsen-Cannarella S., Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clinical Transplantation 2006 20 2 226 233 2-s2.0-33646065930 10.1111/j.1399-0012.2005.00473.x
66. Silva E., Alba A., Castro A., Carrascal M., Buckel E., Aguiló J., Herzog C., Calabrán L., Morales J., Fierro J. A., Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of anti-HLA antibodies. Transplantation Proceedings 2010 42 1 266 269 2-s2.0-76749145931 10.1016/j.transproceed.2009.12.047
67. Duquesnoy R. J., Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Current Opinion in Immunology 2008 20 5 594 601 2-s2.0-50849138145 10.1016/j.coi.2008.06.010
68. Kosmoliaptsis V., Dafforn T. R., Chaudhry A. N., Halsall D. J., Bradley J. A., Taylor C. J., High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Human Immunology 2011 72 11 1049 1059 2-s2.0-80054115346 10.1016/j.humimm.2011.07.303
69. Kosmoliaptsis V., Chaudhry A. N., Sharples L. D., Halsall D. J., Dafforn T. R., Bradley J. A., Taylor C. J., Predicting HLA class i alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2009 88 6 791 798 2-s2.0-70350557124 10.1097/TP.0b013e3181b4a9ff
70. Kosmoliaptsis V., Sharples L. D., Chaudhry A. N., Halsall D. J., Bradley J. A., Taylor C. J., Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2011 91 2 183 190 2-s2.0-78751643078 10.1097/TP.0b013e3181ffff99
71. Rutten C. E., van Luxemburg-Heijs S. A., Halkes C. J., Patient HLA-DP-specific CD4(+) T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. Biology of Blood and Marrow Transplantation 2013 19 1 40 48
72. Pietra B. A., Wiseman A., Bolwerk A., Rizeq M., Gill R. G., CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Journal of Clinical Investigation 2000 106 8 1003 1010 2-s2.0-0033783493
73. Van Emmerik N. E. M., Vaessen L. M. B., Balk A. H. M. M., Bos E., Claas F. H. J., Weimar W., Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection. Transplantation 1996 62 4 529 536 2-s2.0-0029796017 (Pubitemid 26295830)
74. Kjer-Nielsen L., Clements C. S., Purcell A. W., Brooks A. G., Whisstock J. C., Burrows S. R., McCluskey J., Rossjohn J., A structural basis for the selection of Dominant α β T cell receptors in antiviral immunity. Immunity 2003 18 1 53 64 2-s2.0-0037240790 10.1016/S1074-7613(02)00513-7 (Pubitemid 36120687)
75. Macdonald W. A., Chen Z., Gras S., Archbold J. K., Tynan F. E., Clements C. S., Bharadwaj M., Kjer-Nielsen L., Saunders P. M., Wilce M. C. J., Crawford F., Stadinsky B., Jackson D., Brooks A. G., Purcell A. W., Kappler J. W., Burrows S. R., Rossjohn J., McCluskey J., T cell allorecognition via molecular mimicry. Immunity 2009 31 6 897 908 2-s2.0-71749097993 10.1016/j.immuni.2009.09. 025
76. Venturi V., Price D. A., Douek D. C., Davenport M. P., The molecular basis for public T-cell responses? Nature Reviews Immunology 2008 8 3 231 238 2-s2.0-40049103901 10.1038/nri2260 (Pubitemid 351323289)
77. Hislop A. D., Annels N. E., Gudgeon N. H., Leese A. M., Rickinson A. B., Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection. The Journal of Experimental Medicine 2002 195 7 893 905 2-s2.0-0036534769 10.1084/jem.20011692 (Pubitemid 34286760)
78. D'Orsogna L. J., Roelen D. L., Doxiadis I. I. N., Claas F. H. J., TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. Immunogenetics 2012 64 2 77 85 2-s2.0-84857357111 10.1007/s00251-011-0590-0
79. Amir A. L., D'Orsogna L. J., Roelen D. L., Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010 115 15 3146 3157
80. Colf L. A., Bankovich A. J., Hanick N. A., Bowerman N. A., Jones L. L., Kranz D., Garcia K. C., How a single T cell receptor recognizes both self and foreign MHC. Cell 2007 129 1 135 146 2-s2.0-33947726614 10.1016/j.cell.2007.01. 048 (Pubitemid 46507586)
81. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B., Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968 14 2 181 196 2-s2.0-0014251127
82. Jeras M., The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors. Transplant Immunology 2002 10 2-3 205 214 2-s2.0-0036344929 10.1016/S0966- 3274(02)00067-9
83. Roosnek E., Hogendijk S., Zawadynski S., Speiser D., Tiercy J.-M., Helg C., Chapuis B., Gratwohl A., Gmur J., Seger R., Jeannet M., The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation 1993 56 3 691 696 2-s2.0-0027493594 (Pubitemid 23293039)
84. Herzog W.-R., Zanker B., Irschick E., Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation 1987 43 3 384 389 2-s2.0-0023129914 (Pubitemid 17044749)
85. Roelen D. L., Van Beelen E., Van Bree S. P. M. J., Van Rood J. J., Volker-Dieben H. J., Claas F. H. J., The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 1995 59 7 1039 1042 2-s2.0-0028925382
86. Oudshoorn M., Doxiadis I. I. N., Van Den Berg-Loonen P. M., Voorter C. E. M., Verduyn W., Claas F. H. J., Functional versus structural matching: can the CTLp test be replaced by HLA allele typing? Human Immunology 2002 63 3 176 184 2-s2.0-0036126332 10.1016/S0198-8859(01)00384-6 (Pubitemid 34246050)
87. Van Kampen C. A., Roelen D. L., Versteeg-Van Der Voort Maarschalk M. F. J., Hoitsma A. J., Allebes W. A., Claas F. H. J., Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure. Transplantation 2002 74 8 1114 1119 2-s2.0-0037184335 (Pubitemid 35216104)
88. Jöris M. M., Van Rood J. J., Roelen D. L., Oudshoorn M., Claas F. H. J., A proposed algorithm predictive for cytotoxic T cell alloreactivity. Journal of Immunology 2012 188 4 1868 1873 2-s2.0-84856866194 10.4049/jimmunol.1102086
89. Jöris M. M., Lankester A. C., van dem Borne P. A., Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome. Transplantation Immunology 2014 30 2-3 59 64 10.1016/j.trim.2013.08.006
90. Zino E., Frumento G., Marktel S., Sormani M. P., Ficara F., Di Terlizzi S., Parodi A. M., Sergeant R., Martinetti M., Bontadini A., Bonifazi F., Lisini D., Mazzi B., Rossini S., Servida P., Ciceri F., Bonini C., Lanino E., Bandini G., Locatelli F., Apperley J., Bacigalupo A., Ferrara G. B., Bordignon C., Fleischhauer K., A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004 103 4 1417 1424 2-s2.0-10744226154 10.1182/blood-2003-04-1279 (Pubitemid 38168657)
91. Fleischhauer K., Shaw B. E., Gooley T., Malkki M., Bardy P., Bignon J.-D., Dubois V., Horowitz M. M., Madrigal J. A., Morishima Y., Oudshoorn M., Ringden O., Spellman S., Velardi A., Zino E., Petersdorf E. W., Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. The Lancet Oncology 2012 13 4 366 374 2-s2.0-84859161258 10.1016/S1470-2045(12)70004-9
92. Fleischhauer K., Locatelli F., Zecca M., Orofino M. G., Giardini C., De Stefano P., Pession A., Iannone A. M., Carcassi C., Zino E., La Nasa G., Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006 107 7 2984 2992 2-s2.0-33645498109 10.1182/blood-2005-08-3374
93. Elsner H.-A., DeLuca D., Strub J., Blasczyk R., HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool. Bone Marrow Transplantation 2004 33 2 165 169 2-s2.0-0842323947 10.1038/sj.bmt.1704301 (Pubitemid 38180928)
94. Shaw B. E., Barber L. D., Madrigal J. A., Cleaver S., Marsh S. G. E., Elsner H. A., Blasczyk R., Scoring for HLA matching? A clinical test of HistoCheck. Bone Marrow Transplantation 2004 34 4 367 369 2-s2.0-4444282360 10.1038/sj.bmt.1704586 (Pubitemid 39172446)
95. Askar M., Sobecks R., Morishima Y., Kawase T., Nowacki A., Makishima H., Maciejewski J., Predictions in the face of clinical reality: histoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 2011 17 9 1409 1415 2-s2.0-80051664480 10.1016/j.bbmt.2011.01.015
96. Spellman S., Klein J., Haagenson M., Askar M., Baxter-Lowe L. A., He J., Hsu S., Blasczyk R., Hurley C., Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2012 18 5 739 746 2-s2.0-84859826556 10.1016/j.bbmt.2011.09.008
97. Pidala J., Wang T., Haagenson M., Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood 2013 122 22 3651 3658 10.1182/blood-2013-05-501510
98. Ferrara G. B., Bacigalupo A., Lamparelli T., Lanino E., Delfino L., Morabito A., Parodi A. M., Pera C., Pozzi S., Sormani M. P., Bruzzi P., Bordo D., Bolognesi M., Bandini G., Bontadini A., Barbanti M., Frumento G., Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001 98 10 3150 3155 2-s2.0-0035892137 10.1182/blood.V98.10.3150
99. 2013, http://www.syfpeithi.de/
100. Suciu-Foca N., Ciubotariu R., Itescu S., Rose E. A., Cortesini R., Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts. Transplantation Proceedings 1998 30 8 3999 4000 2-s2.0-0032411345 10.1016/S0041-1345(98)01318-9 (Pubitemid 29013134)
101. Liu Z., Colovai A. I., Tugulea S., Reed E. F., Fisher P. E., Mancini D., Rose E. A., Cortesini R., Michler R. E., Suciu-Foca N., Indirect recognition of donor HLA-DR peptides in organ allograft rejection. Journal of Clinical Investigation 1996 98 5 1150 1157 2-s2.0-9544241307 (Pubitemid 26299928)
102. Ciubotariu R., Liu Z., Colovai A. I., Ho E., Itescu S., Ravalli S., Hardy M. A., Cortesini R., Rose E. A., Suciu-Foca N., Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. Journal of Clinical Investigation 1998 101 2 398 405 2-s2.0-0032518422 (Pubitemid 28067337)
103. Hornick P. I., Mason P. D., Baker R. J., Hernandez-Fuentes M., Frasca L., Lombardi G., Taylor K., Weng L., Rose M. L., Yacoub M. H., Batchelor R., Lechler R. I., Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000 101 20 2405 2410 2-s2.0-0034705008 (Pubitemid 30329132)
104. Afzali B., Lechler R. I., Hernandez-Fuentes M. P., Allorecognition and the alloresponse: clinical implications. Tissue Antigens 2007 69 6 545 556 2-s2.0-34248335371 10.1111/j.1399-0039.2007.00834.x (Pubitemid 46733686)
105. Otten H. G., Calis J. J., Keşmir C., van Zuilen A. D., Spierings E., Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. Human Immunology 2013 74 3 290 296 10.1016/j.humimm.2012.12.004
106. Zhang L., Udaka K., Mamitsuka H., Zhu S., Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. Briefings in Bioinformatics 2012 13 3 350 364 10.1093/bib/bbr060
107. Nielsen M., Lundegaard C., Lund O., Keşmir C., The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005 57 1-2 33 41 2-s2.0-17844385106 10.1007/s00251-005-0781-7 (Pubitemid 40591245)
108. Hoof I., Peters B., Sidney J., Pedersen L. E., Sette A., Lund O., Buus S., Nielsen M., NetMHCpan, a method for MHC class i binding prediction beyond humans. Immunogenetics 2009 61 1 1 13 2-s2.0-59449094834 10.1007/s00251-008- 0341-z
109. Nielsen M., Lundegaard C., Blicher T., Lamberth K., Harndahl M., Justesen S., Røder G., Peters B., Sette A., Lund O., Buus S., NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2007 2 8, article e796 2-s2.0-39549084433 10.1371/journal.pone.0000796 (Pubitemid 351386580)
110. Nielsen M., Lund O., NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009 10, article 1471 296 2-s2.0-70449359806 10.1186/1471-2105- 10-296
111. Nielsen M., Lundegaard C., Lund O., Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007 8, article 238 2-s2.0-34547778364 10.1186/1471-2105-8-238 (Pubitemid 47225391)
112. Nielsen M., Justesen S., Lund O., Lundegaard C., Buus S., NetMHCIIpan-2.0-improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Research 2010 6 1, article 9 2-s2.0-78149354807 10.1186/1745-7580-6-9
113. Brusic V., Rudy G., Honeyman M., Hammer J., Harrison L., Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 1998 14 2 121 130 2-s2.0-0031825709 (Pubitemid 28395870)
114. Parker K. C., Bednarek M. A., Coligan J. E., Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. Journal of Immunology 1994 152 1 163 175 2-s2.0-0028052724
115. Rammensee H.-G., Bachmann J., Emmerich N. P. N., Bachor O. A., Stevanović S., SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999 50 3-4 213 219 2-s2.0-0033388725 (Pubitemid 30099526)
116. Nussbaum A. K., Kuttler C., Hadeler K.-P., Rammensee H.-G., Schild H., PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 2001 53 2 87 94 2-s2.0-0035074032 10.1007/s002510100300 (Pubitemid 32289623)
117. Keşmir C., Nussbaum A. K., Schild H., Detours V., Brunak S., Prediction of proteasome cleavage motifs by neural networks. Protein Engineering 2002 15 4 287 296 2-s2.0-0036096708 (Pubitemid 34532767)
118. Peters B., Bulik S., Tampe R., Van Endert P. M., Holzhütter H.-G., Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. Journal of Immunology 2003 171 4 1741 1749 2-s2.0-0041589474 (Pubitemid 36966457)
119. Buus S., Lauemøller S. L., Worning P., Kesmir C., Frimurer T., Corbet S., Fomsgaard A., Hilden J., Holm A., Brunak S., Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach. Tissue Antigens 2003 62 5 378 384 2-s2.0-10744222046 10.1034/j.1399-0039.2003.00112.x (Pubitemid 37345160)
120. Zhang G. L., Petrovsky N., Kwoh C. K., August J. T., Brusic V., PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Research 2006 2, article 3 10.1186/1745-7580-2-3
121. Chen P., Rayner S., Hu K.-H., Advances of bioinformatics tools applied in virus epitopes prediction. Virologica Sinica 2011 26 1 1 7 2-s2.0-79952256874 10.1007/s12250-011-3159-4
122. Ferrara J. L., Levine J. E., Reddy P., Holler E., Graft-versus-host disease. The Lancet 2009 373 9674 1550 1561 2-s2.0-65349171937 10.1016/S0140-6736(09)60237-3
123. Sant'Angelo D. B., Robinson E., Janeway C. A. Jr., Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor. European Journal of Immunology 2002 32 9 2510 2520
124. Rudolph M. G., Stanfield R. L., Wilson I. A., How TCRs bind MHCs, peptides, and coreceptors. Annual Review of Immunology 2006 24 419 466 2-s2.0-33646181088 10.1146/annurev.immunol.23.021704.115658